Cardiovascular effects induced by rolipram, a selective cAMP phosphodiesterase inhibitor: interaction with adrenergic and calcium affecting drugs.
Novara
V
V
Institute of Pharmacology, Faculty of Medicine and Surgery, University of Palermo, Italy.
Flugy
A
A
Antona
A
A
Latteri
S
S
Palazzoadriano
M
M
Cannizzaro
G
G
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000037:antagonists & inhibitors*; D000818:Animals; D002120:Calcium Channel Agonists / Q000494:pharmacology*; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D006439:Hemodynamics / Q000187:drug effects*; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology*; D011760:Pyrrolidinones / Q000494:pharmacology*; D011817:Rabbits; D020889:Rolipram; D013566:Sympathomimetics / Q000494:pharmacology*
D002120:Calcium Channel Agonists; D002121:Calcium Channel Blockers; D010726:Phosphodiesterase Inhibitors; D011760:Pyrrolidinones; D013566:Sympathomimetics; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D020889:Rolipram